ENCell Co Ltd
456070
Company Profile
Business description
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.
Contact
701 Yeongdong-daero
11th floor
Gangnam-gu
Seoul
KORT: +82 262058050
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,741.90 | 26.70 | -0.30% |
| CAC 40 | 7,806.30 | 16.03 | 0.21% |
| DAX 40 | 24,319.99 | 3.59 | -0.01% |
| Dow JONES (US) | 42,803.29 | 483.55 | 1.14% |
| FTSE 100 | 8,834.33 | 23.29 | 0.26% |
| HKSE | 23,792.54 | 114.43 | -0.48% |
| NASDAQ | 19,546.53 | 248.08 | 1.29% |
| Nikkei 225 | 37,741.61 | 187.12 | 0.50% |
| NZX 50 Index | 12,563.48 | 13.67 | -0.11% |
| S&P 500 | 6,005.44 | 66.14 | 1.11% |
| S&P/ASX 200 | 8,515.70 | 23.20 | -0.27% |
| SSE Composite Index | 3,385.36 | 1.26 | 0.04% |